IFLScience on MSN

Fancy Seeing Your Organs In 4D? Pretty Soon, You Might Be Able To

“The originality of these results lies in the fact that these images allow us to visualise the vessels of an entire organ at ...
Yahoo Finance

Advanced (3D/4D) Visualization Systems Market Is Projected to Reach US$ 2,761.6 Million, Growing at A CAGR of 4.2% For 2022-2028 - Comprehensive Research Report by FMI

The prevalence of lifestyle diseases, such as diabetes, cardiovascular disease, cancer, and neurological disorders, has increased due to the rising geriatric population, changing lifestyle, and ...
insideHPC

Toolkit Delivers 4D Visualization, Addresses Data Volume Challenges in Exascale

The Exascale Computing Project (ECP) has announced that a team of researchers has developed the Feature Tracking Kit (FTK), which uses simplicial spacetime meshing to simplify, scale, and deliver ...
Yahoo Finance

Ireland Advanced (3D/4D) Visualization Systems Market Report and Forecasts to 2032

Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Ireland Advanced (3D/4D) Visualization Systems Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032" report has been added to ...
Stockhouse

Astellas and 4D Molecular Therapeutics (4DMT) Enter into License Agreement to Use 4DMT's Proprietary Intravitreal R100 Vector for Rare Ophthalmic Targets

TOKYO and EMERYVILLE, Calif., July 10, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") and 4D Molecular ...
Nasdaq

4D Molecular Therapeutics Announces Collaboration on Leading Machine Learning Technology and Expertise from U.C. Berkeley to Expand Therapeutic Vector Evolution Platform

EMERYVILLE, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene ...
Business Wire

4D Molecular Therapeutics and Roche Sign Collaboration Agreement for Gene Therapy Vector Discovery and Product Development

SAN FRANCISCO--(BUSINESS WIRE)--4D Molecular Therapeutics (4DMT), a leader in next-generation gene therapy vector discovery and product development, today announced a collaboration and license ...